Qui sommes-nous ?
L'ANSM en bref
Nos engagements
Nos missions
Notre périmètre
Notre organisation
Déontologie et transparence
Publications institutionnelles
Publications scientifiques
Rejoignez-nous !
Notre agenda
 
Actualités
Nos articles
Nos campagnes
 
Bulletin officiel des actes, décisions et avis
Décisions institutionnelles
Décisions liées aux médicaments
Décisions liées aux produits sanguins et autres produits biologiques
Décisions liées aux médicaments dérivés du plasma
Décisions liées aux dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Injonctions
Décisions de police sanitaire
Sanctions financières
Avis
 
Disponibilité des produits de santé
Médicaments
Dispositifs médicaux et dispositifs médicaux de diagnostic in vitro
Vaccins
 
Vos démarches
Industriel
Organismes notifiés
Professionnel de santé
Patient
Chercheur

Our missions

A+ A-
As an agency responsible for providing expertise and supporting decision-making, ANSM acts in the interest of patients by ensuring the safety of health products. It dialogues with patients and healthcare professionals on an ongoing basis, to inform its action in the light of real-life practices and needs. In its role as a national competent authority, it represents France and engages in dialogue with European and international bodies. It then endeavours to ensure that its decisions are known and understood, so that the greatest number may   be aware of them, thereby promoting everyone’s safety.
 

Providing tools and references

 
View reference documents

Defining good practices

Inspections apply to all human health products and cosmetic products. To this end, ANSM is involved in drafting texts applicable to operators, particularly good practices defined in decisions made by the Director General.
  • Good Laboratory Practice (GLP) provides the framework applied by all trial facilities in countries adhering to the OECD Mutual Acceptance of Data system to ensure the quality and international admissibility of non-clinical safety studies.
  • Good Clinical Practice (GCP) provides the framework for clinical trials on medicines.
  • Good Manufacturing Practice (GMP) provides the framework to be applied by all manufacturers and importers of medicines, including innovative therapy medicines, and active substances used in their composition, and also by operators marketing proprietary medicines.
  • Good Wholesale Distribution Practice (GWDP) of medicines provides the framework to be applied by all wholesalers carrying out logistical operations, but also by medicine operators and brokers.
  • Good Pharmacovigilance Practice (GVP) defines the role and obligations of the various parties involved in the pharmacovigilance system: healthcare professionals, regional pharmacovigilance centres, businesses or organisations operating medicines, and also patients and patient associations. It supplements European Good Pharmacovigilance Practices on a national level.
  • Good Distribution Practice (GDP) for active substances applies to sites carrying out distribution operations in respect of active substances for human use.
  • Good Preparation Practice (GPP) applies to preparations prepared in hospital and community pharmacies.
  • Good Cell and Tissue Culture Practice provides the frameworks applicable to the extraction, preparation, storage, transport, distribution and sale/transfer of tissues and cells of human origin.
  • Good Transfusion Practice applies to all operations in the transfusion chain, from the collection to the delivery of labile blood products, including donation qualification.
  • Good Breast Milk Bank Practice applies to the manufacture and safeguarding breast milk from breast milk banks.
  • Good practice aimed at ensuring biological safety and security applies to Microorganisms and Toxin (MOT) authorisation holders and the directors of the sites concerned.
  • In the case of medical devices and in vitro diagnostic medical devices, the applicable references are the harmonised European standards ensuring compliance with the essential requirements in respect of safety and health.